Renal glucose reabsorption inhibitors to treat diabetes
- 5 January 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 32 (2), 63-71
- https://doi.org/10.1016/j.tips.2010.11.011
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and ExerciseDiabetes Care, 2010
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin SensitizersDiabetes Care, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 DiabetesDiabetes Care, 2008
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With MetforminArchives of Internal Medicine, 2008
- Metabolic Syndrome and Incident DiabetesDiabetes Care, 2008
- Diabetes associated cell stress and dysfunction: role of mitochondrial and non‐mitochondrial ROS production and activityThe Journal of Physiology, 2007
- A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placeboBMC Endocrine Disorders, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006